OPC-6535(Tetomilast)

( DrugBank: Tetomilast / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00317369 (ClinicalTrials.gov)	May 2006	21/4/2006	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	Crohn Disease	Drug: OPC-6535(Tetomilast)	Otsuka Pharmaceutical Co., Ltd.	NULL	Terminated	16 Years	65 Years	Both	60	Phase 2	Japan

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00317356 (ClinicalTrials.gov)	May 2006	21/4/2006	A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis	A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis	Colitis, Ulcerative	Drug: OPC-6535(Tetomilast)	Otsuka Pharmaceutical Co., Ltd.	NULL	Terminated	18 Years	65 Years	Both	160	Phase 2	Japan